Announcements Trials

Browse Landscape

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 10 Lymphoid 10 Other hematologic neoplasm 8 Myeloid 6 CNS 4 Sarcoma 2 Dermatologic 2 Thoracic 1 Other solid neoplasm 1 Gynecologic 1 Genitourinary 1 Gastrointestinal 1

Conditions

Interventions

Cisplatin 60 Carboplatin 55 Cyclophosphamide 47 Pemetrexed 45 Irinotecan 33 pembrolizumab 32 Paclitaxel 29 Etoposide 29 Gemcitabine 28 Nivolumab 24 Bevacizumab 24 Interviews as Topic 23 Vincristine 22 Capecitabine 22 Topotecan 20 Filgrastim 20 Early Intervention, Educational 20 fludarabine 19 Oxaliplatin 19 Docetaxel 19 Specimen Handling 18 Drug Therapy 18 Temozolomide 17 Sorafenib 17 Leucovorin 17 Everolimus 17 Educational Status 17 Radiotherapy 16 Methods 16 Fluorouracil 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Blood Component Removal × Other solid neoplasm × Clear all

NCT07137312 2025-12-23

Ex Vivo Expansion (ACT-X)

Mayo Clinic

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡